GlassScriptPhysician profile
Michael D Atwell
NPI 1790055648
$1,607.86
in general payments reported to CMS, 2019-2025
20 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $380 · 2022: $16.51 · 2023: $957 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $608 · Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $607.72 |
| Food and Beverage | $603.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $437.80 | 2023 | |
| Crossroads Orthopedics, LLC | $389.39 | 2023 | |
| Stryker Corporation | $134.11 | 2025 | Tornier Perform Reversed Augmented Glenoid, Tornier Perform Reversed Glenoid |
| Zimmer Biomet Holdings, INC. | $113.88 | 2023 | |
| Medtronic, INC. | $104.35 | 2025 | Inceptiv |
| Nevro Corp. | $98.03 | 2021 | |
| Abbvie INC. | $66.71 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $54.05 | 2021 | |
| Vertos Medical, INC. | $31.47 | 2021 | |
| Almatica Pharma LLC | $26.92 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.77 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $17.11 | 2021 | |
| Amgen INC. | $16.93 | 2021 | |
| Ethicon US, LLC | $16.31 | 2025 | Dermabond |
| Kci USA, INC. | $15.70 | 2023 | Prevena |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $15.44 | 2021 | |
| Allergan, INC. | $14.24 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.06 | 2021 | |
| Boston Scientific Corporation | $11.88 | 2021 | |
| Novo Nordisk INC | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Atwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.